{"id":"NCT01773070","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study","officialTitle":"A Follow-up Study to Assess Resistance and Durability of Response to AbbVie Direct-Acting Antiviral Agent (DAA) Therapy in Subjects Who Participated in Phase 2 or 3 Clinical Studies for the Treatment of Chronic Hepatitis C Virus (HCV) Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2016-10","completion":"2016-10","firstPosted":"2013-01-23","resultsPosted":"2017-11-06","lastUpdate":"2017-12-06"},"enrollment":478,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Hepatitis C"],"interventions":[{"type":"DRUG","name":"ABT-450/ritonavir","otherNames":["ABT-450 also known as paritaprevir"]},{"type":"DRUG","name":"ABT-333","otherNames":["dasabuvir"]},{"type":"DRUG","name":"ABT-267","otherNames":["ombitasvir"]}],"arms":[{"label":"All Participants","type":"OTHER"}],"summary":"A follow-up study to assess resistance and durability of response to 3 experimental drugs ABT-450/r, ABT-267, and ABT-333 in participants who have participated in AbbVie Phase 2 or 3 clinical studies with these agents for the treatment of chronic hepatitis C virus (HCV). Studies include: M11-646 (NCT01716585), M11-652 (NCT01464827), M12-746 (NCT01306617), M12-998 (NCT01458535), M13-098 (NCT01715415), M13-099 (NCT01704755), M13-386 (NCT01563536), M13-389 (NCT01674725)' M13-393 (NCT01685203), M13-961 (NCT01767116), M14-002 (NCT01833533), and M14-103 (NCT01911845).","primaryOutcome":{"measure":"Percentage of Participants Who Experienced Relapse12overall With and Without New HCV Infection","timeFrame":"Up to 3 years post-treatment","effectByArm":[{"arm":"All Participants","deltaMin":0.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":478},"commonTop":[]}}